Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard L McLeod

Showing results (11-20 of 386) with videos related to

Pageof 39
Sort By:
Expert Opinion on Pharmacotherapy|January 30, 2007
Pharmacogenetics and oncology treatment for breast cancerSharon Marsh, Howard L McLeod
Cancer Investigation|October 10, 2003
Cancer pharmacogenomics: SNPs, chips, and the individual patientHoward L McLeod, Jinsheng Yu
Nature Genetics|July 29, 2005
Pharmacogenetics goes 3DHoward L McLeod, Sharon Marsh
Anti-Cancer Drugs|August 13, 2005
PI3K/Akt/mTOR pathway as a target for cancer therapyDaniel Morgensztern, Howard L McLeod
Pharmacogenomics|April 23, 2002
The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomicsHoward L McLeod, Chokkalingam Siva
Cancer Journal (Sudbury, Mass.)|October 4, 2005
Pharmacogenetics and pediatric cancerLisa Bomgaars, Howard L McLeod
Arthritis and Rheumatism|February 5, 2005
Methotrexate and long-term treatment of rheumatic disease: comment on the article by KremerPrabha Ranganathan, Howard L McLeod
Pharmacogenomics|March 30, 2007
Primum non nocere: adverse drug events must be taken seriouslyDavid Gurwitz, Howard L McLeod
Human Molecular Genetics|May 3, 2006
Pharmacogenomics: from bedside to clinical practiceSharon Marsh, Howard L McLeod
Advanced Drug Delivery Reviews|January 27, 2009
Genomics: applications in mechanism elucidationVenita Gresham, Howard L McLeod
Pageof 39

Showing results (11-20 of 386) with videos related to

Sort By:
Pageof 39
Expert Opinion on Pharmacotherapy|January 30, 2007
Pharmacogenetics and oncology treatment for breast cancerSharon Marsh, Howard L McLeod
Cancer Investigation|October 10, 2003
Cancer pharmacogenomics: SNPs, chips, and the individual patientHoward L McLeod, Jinsheng Yu
Nature Genetics|July 29, 2005
Pharmacogenetics goes 3DHoward L McLeod, Sharon Marsh
Anti-Cancer Drugs|August 13, 2005
PI3K/Akt/mTOR pathway as a target for cancer therapyDaniel Morgensztern, Howard L McLeod
Pharmacogenomics|April 23, 2002
The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomicsHoward L McLeod, Chokkalingam Siva
Cancer Journal (Sudbury, Mass.)|October 4, 2005
Pharmacogenetics and pediatric cancerLisa Bomgaars, Howard L McLeod
Arthritis and Rheumatism|February 5, 2005
Methotrexate and long-term treatment of rheumatic disease: comment on the article by KremerPrabha Ranganathan, Howard L McLeod
Pharmacogenomics|March 30, 2007
Primum non nocere: adverse drug events must be taken seriouslyDavid Gurwitz, Howard L McLeod
Human Molecular Genetics|May 3, 2006
Pharmacogenomics: from bedside to clinical practiceSharon Marsh, Howard L McLeod
Advanced Drug Delivery Reviews|January 27, 2009
Genomics: applications in mechanism elucidationVenita Gresham, Howard L McLeod
Pageof 39